Physician profile
Setu Dalal
NPI 1013180447
$7,689.01
in general payments reported to CMS, 2019-2025
16 companies · $7,105 in 2025
The $7,105 reported for 2025 was more than what 93% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $137 · 2021: $148 · 2022: $49.43 · 2023: $91.81 · 2024: $48.96 · 2025: $7,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,142 · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,141.76 |
| Food and Beverage | $604.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,967.62 | 2025 | |
| Smith+Nephew, INC. | $170.28 | 2019-2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $128.61 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $87.48 | 2019-2021 | |
| Dilon Technologies, INC. | $46.39 | 2025 | Hemoblast Bellows |
| Polarityte, INC. | $45.00 | 2020 | |
| Kci USA, INC. | $40.69 | 2021 | |
| Zimmer Biomet Holdings, INC. | $34.70 | 2025 | Ribfix Titan |
| Astrazeneca Pharmaceuticals Lp | $29.80 | 2024 | Andexxa |
| Kerecis Limited | $28.65 | 2022 | |
| Ucb, INC. | $26.87 | 2021 | |
| Bioventus LLC | $20.78 | 2022 | |
| Cook Medical LLC | $19.58 | 2025 | Blue Rhino |
| Acell, INC. | $15.32 | 2020 | |
| Shire North American Group INC | $13.62 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Setu Dalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.